Product Information
KETAMINE 500 MG/5 ML VIAL is a generic product labeled by Hospira Inc., priced at $1.5501 per ML under NDC 00409004010. Its NADAC has been published 32 times since Nov 19, 2025.
The High Outlier badge above means this manufacturer's average price in the KETAMINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/mL
Manufacturer
Hospira Inc.NDC
00409004010
Classification
Generic
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
KETAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074549On Market Since
10/10/2022
Pharmacological Classes
Price Statistics
The NADAC for KETAMINE 500 MG/5 ML VIAL has been published 32 times since Nov 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5501 per ML |
|---|---|
| All-time high | $1.5655 (May 13, 2026) |
| All-time low | $1.5501 (Jun 17, 2026) |
| 52-week high | $1.5655 |
| 52-week low | $1.5501 |
| Median price | $1.5611 |
| Average price | $1.5610 |
| Largest weekly change | -0.6% (Jun 17, 2026) |
| Weeks tracked | 32 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the KETAMINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of KETAMINE 500 MG/5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETAMINE 500 MG/5 ML VIAL, manufactured by Hospira Inc., is $1.5501 per ML (NDC 00409004010), effective Jun 24, 2026.
How has the price of KETAMINE 500 MG/5 ML VIAL changed over time?
Over the history we have for it, the NADAC for KETAMINE 500 MG/5 ML VIAL has held within roughly two percent of its current level. It has been tracked across 32 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for KETAMINE 500 MG/5 ML VIAL?
Since Nov 19, 2025, the NADAC for KETAMINE 500 MG/5 ML VIAL has ranged from a low of $1.5501 (Jun 17, 2026) to a high of $1.5655 (May 13, 2026), with a median of $1.5611 per ML.
Are there cheaper alternatives to KETAMINE 500 MG/5 ML VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of KETAMINE 500 MG/5 ML VIAL, so no direct lower-cost alternative is listed.
Who manufactures KETAMINE 500 MG/5 ML VIAL?
KETAMINE 500 MG/5 ML VIAL (NDC 00409004010) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification